Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: A systematic review and metaanalysis

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 1, 2013, Pages 40.e1-40.e17

  Conde Agudelo, Agustin ^a,b   Nieto, Anibal ^c   Rosas Bermudez, Anyeli ^d   Romero, Roberto ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Universidad de Murcia ^*

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Blood loss; Oxytocin; Postpartum hemorrhage; Pregnancy; Uterotonics

Indexed keywords

ERGOMETRINE; HEMOGLOBIN; MISOPROSTOL; OXYTOCIN; PLACEBO;

CESAREAN SECTION; CLINICAL EVALUATION; DRUG EFFICACY; DRUG SAFETY; FEVER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE MOTILITY; INTRAOPERATIVE PERIOD; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHIVERING; SYSTEMATIC REVIEW;

EID: 84880134027     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.03.015     Document Type: Article

References (66)

1. Gibbons L, Belizan JM, Lauer JA, Betran AP, Merialdi M, Althabe F. Inequities in the use of cesarean section deliveries in the world. Am J Obstet Gynecol 2012;206:331.e1-331.e19.
2. Ananth CV, Vintzileos AM. Trends in cesarean delivery at preterm gestation and association with perinatal mortality. Am J Obstet Gynecol 2011;204:505.e1-8.
3. Zhang J, Troendle J, Reddy UM, et al. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010;203: 326.e1-10.
4. Klemetti R, Che X, Gao Y, et al. Cesarean section delivery among primiparous women in rural China: An emerging epidemic. Am J Obstet Gynecol 2010;202:65.e1-6.
5. Getahun D, Strickland D, Lawrence JM, Fassett MJ, Koebnick C, Jacobsen SJ. Racial and ethnic disparities in the trends in primary cesarean delivery based on indications. Am J Obstet Gynecol 2009;201:422.e1-7.
6. Brennan DJ, Robson MS, Murphy M, O'Herlihy C. Comparative analysis of international cesarean delivery rates using 10-group classification identifies significant variation in spontaneous labor. Am J Obstet Gynecol 2009;201:308.e1-8.
7. Tang S, Li X, Wu Z. Rising cesarean delivery rate in primiparous women in urban China: Evidence from three nationwide household health surveys. Am J Obstet Gynecol 2006;195: 1527-32. (Pubitemid 44792607)
8. Bailit JL, Love TE, Mercer B. Rising cesarean rates: Are patients sicker? Am J Obstet Gynecol 2004;191:800-3. (Pubitemid 39298113)
9. Betrán AP, Merialdi M, Lauer JA, et al. Rates of cesarean section: Analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007;21:98-113.
10. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet 2006;367:1066-74.
11. Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF. Investigation of an increase in postpartum hemorrhage in Canada. BJOG 2007;114:751-9. (Pubitemid 46788638)
12. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet 2007;98:237-43. (Pubitemid 47210992)
13. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010;202: 353.e1-6.
14. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010;110:1368-73.
15. American College of Obstetricians and Gynecologists. ACOG practice bulletin: Clinical management guidelines for obstetriciangynecologists no. 76; postpartum hemorrhage. Obstet Gynecol 2006;108:1039-47.
16. Pritchard JA, Baldwin RM, Dickey JC, Wiggins KM, Reed GP, Bruce DM. Blood volume changes in pregnancy and the puerperium, II: Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean plus total hysterectomy. Am J Obstet Gynecol 1962;84: 1271-82.
17. Magann EF, Evans S, Hutchinson M, Collins R, Lanneau G, Morrison JC. Postpartum hemorrhage after cesarean delivery: An analysis of risk factors. South Med J 2005;98:681-5. (Pubitemid 41061652)
18. Al-Zirqi I, Vangen S, Forsén L, Stray-Pedersen B. Effects of onset of labor and mode of delivery on severe postpartum hemorrhage. Am J Obstet Gynecol 2009;201:273. e1-9.
19. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum hemorrhage: A systematic review. Best Pract Res Clin Obstet Gynaecol 2008;22:999-1012.
20. Kolås T, Øian P, Skjeldestad FE. Risks for peroperative excessive blood loss in cesarean delivery. Acta Obstet Gynecol Scand 2010;89: 658-63.
21. Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk factors for postpartum hemorrhage: Can we explain the recent temporal increase? J Obstet Gynaecol Can 2011;33:810-9.
22. Chang CC, Wang IT, Chen YH, Lin HC. Anesthetic management as a risk factor for postpartum hemorrhage after cesarean deliveries. Am J Obstet Gynecol 2011;205:462. e1-7.
23. Skjeldestad FE, Oian P. Blood loss after cesarean delivery: A registry-based study in Norway, 1999-2008. Am J Obstet Gynecol 2012;206:76.e1-7.
24. Larsson C, Saltvedt S, Wiklund I, Pahlen S, Andolf E. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand 2006;85:1448-52. (Pubitemid 44863762)
25. Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008;199:519.e1-7.
26. Toledo P, McCarthy RJ, Burke CA, Goetz K, Wong CA, Grobman WA. The effect of live and web-based education on the accuracy of blood-loss estimation in simulated obstetric scenarios. Am J Obstet Gynecol 2010;202: 400.e1-5.
27. Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labor. Cochrane Database Syst Rev 2011;11: CD007412.
28. National Collaborating Center for Women's and Children's Health. Cesarean section: NICE clinical guideline. London: RCOG Press; 2011.
29. Bonanno C, Gaddipati S. Mechanisms of hemostasis at cesarean delivery. Clin Perinatol 2008;35:531-47.
30. Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labor and cesarean delivery: Implications for the anesthesiologist. Curr Opin Anaesthesiol 2011;24:255-61.
31. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum hemorrhage. Cochrane Database Syst Rev 2012;8:CD000494.
32. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. Ann Intern Med 2009;151: W65-94.
33. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Cochrane Collaboration; 2011.
34. Deeks JJ, Higgins JPT, Altman DG. Analyzing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Cochrane Collaboration; 2011.
35. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ 2003;327:557-60.
36. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317: 1309-12. (Pubitemid 28502420)
37. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analyses detected by a simple graphical test. BMJ 1997;315: 629-34. (Pubitemid 27387172)
38. Zhao Y, Li X, Peng Y. Clinical study on reduction of postpartum bleeding in cesarean section by misoprostol [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 1998;33:403-5.
39. Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T. A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section. Acta Obstet Gynecol Scand 2001;80:245-50. (Pubitemid 32173561)
40. Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, Refaey HE, Rodeck CH. Active management of the third stage at cesarean section: A randomized controlled trial of misoprostol versus syntocinon. Aust N Z J Obstet Gynaecol 2001;41:411-4. (Pubitemid 33100679)
41. Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K. Buccal misoprostol to prevent hemorrhage at cesarean delivery: A randomized study. Am J Obstet Gynecol 2005;192: 1404-6.
42. Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet 2006;92:106-10. (Pubitemid 43098864)
43. Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM. Oral misoprostol vs intravenous oxytocin in reducing blood loss after emergency cesarean delivery. Int J Gynaecol Obstet 2006;95:2-7. (Pubitemid 44310665)
44. Quiroga Díaz R, Cantú Mata R, Tello Gutiérrez HE, Puente Villalobos M, Montemayor Garza R, Martínez Mendoza A. Intrauterine misoprostol for the prevention of bleeding cesarean [in Spanish]. Ginecol Obstet Mex 2009;77:469-74.
45. Eftekhari N, Doroodian M, Lashkarizadeh R. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after cesarean section. J Obstet Gynaecol 2009;29: 633-6.
46. Fekih M, Jnifene A, Fathallah K, et al. Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: A randomized controlled trial [in French]. J Gynecol Obstet Biol Reprod (Paris) 2009;38: 588-93.
47. Chaudhuri P, Banerjee GB, Mandal A. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss. Int J Gynaecol Obstet 2010;109: 25-9.
48. Chalermpolprapa MD. Efficacy of sublingual misoprostol in prevention of postpartum hemorrhage in cesarean section: A randomized double-blinded, placebo-controlled trial [in Thai]. Reg 4-5 Med J 2010;29:325-35.
49. Owonikoko KM, Arowojolu AO,Okunlola MA. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: A randomized controlled trial. J Obstet Gynaecol Res 2011;37: 715-21.
50. Sood AK, Singh S. Sublingual misoprostol to reduce blood loss at cesarean delivery. J Obstet Gynecol India 2012;62:162-7.
51. Ali R, Hina F. Postpartum hemorrhage: Comparison of efficacy of ergometrine with misoprostol in prophylaxis in cesarean section. Prof Med J 2012;19:86-90.
52. Elsedeek MS. Impact of preoperative rectal misoprostol on blood loss during and after elective cesarean delivery. Int J Gynaecol Obstet 2012;118:149-52.
53. El Tahan MR, Warda OM, Rashad A, et al. Effects of preoperative sublingual misoprostol on uterine tone during isoflurane anesthesia for cesarean section. Rev Bras Anestesiol 2012;62: 625-35.
54. Gavilanes Sáenz VP, Morales Carrasco MF, Velasco Jácome SM. Comparison of the efficacy between misoprostol and oxytocin in the prevention of hemorrhage during cesarean section in pregnant women at 34 weeks' gestation in the gynecological and obstetrical hospital "Isidro Ayora," 2011-2012 [postgraduate thesis] [in Spanish]. Quito (Ecuador): Universidad Central del Ecuador; 2012. Available at: Http://www.dspace.uce.edu. ec/bitstream/25000/634/1/T-UCE-0006-18.pdf. Accessed Feb. 6, 2013.
55. Chu CS, Brhlikova P, Pollock AM. Rethinking WHO guidance: Review of evidence for misoprostol use in the prevention of postpartum hemorrhage. J R Soc Med 2012;105:336-47.
56. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum hemorrhage. Cochrane Database Syst Rev 2012;2: CD009336.
57. Chelmow D. Postpartum hemorrhage: Prevention. Clin Evid (Online) 2011;2011.
58. Gibbens D, Boyd NR, Crocker S, Baumber S, Chard T. The circulating levels of oxytocin following intravenous and intramuscular administration of Syntometrine. J Obstet Gynaecol Br Commonw 1972;79:644-6.
59. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side effects. Int J Gynaecol Obstet 2007;99(Suppl):S160-7. (Pubitemid 350101541)
60. Treadwell J, Uhl S, Tipton K, et al. Assessing equivalence and noninferiority: AHRQ publication no. 12-EHC045-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
61. Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum hemorrhage. Cochrane Database Syst Rev 2012;4:CD005457.
62. Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labor: Prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009;31: 980-93.
63. Häger RM, Daltveit AK, Hofoss D, et al. Complications of cesarean deliveries: Rates and risk factors. Am J Obstet Gynecol 2004;190: 428-34. (Pubitemid 38249240)
64. Hu BM, Liu X, Chen ZY. Effect of misoprostol on gastrointestinal peristalsis after cesarean section [in Chinese]. Chin J Prim Med Pharm 2008;15:1297-8.
65. Çayan F, Doruk A, Sungur MA, Dilek S. Comparison of the different dosages of rectal misoprostol on intestinal motility and pain score in high risk cesarean delivery. Turkiye Klinikleri J Med Sci 2010;30:1154-9.
66. Adanikin AI, Orji EO, Fasubaa OB, Onwudiegwu U, Ijarotimi OA, Olaniyan O. The effect of post-cesarean rectal misoprostol on intestinal motility. Int J Gynaecol Obstet 2012;119:159-62. Development